PRF1 and neoplasm: Unexpectedly, loss of perforin delayed tumor onset, with median latency increasing from 72 to 84 days (Figure 1D), a finding that contrasts with the expected acceleration of tumor growth typically observed in immunocompromised mice (24, 25).